• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correspondence re: G. C. de Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6: 1267-1272, 2000.

作者信息

Meyers F J, O' Donnell R T

出版信息

Clin Cancer Res. 2000 Oct;6(10):4167.

PMID:11051273
Abstract
摘要

相似文献

1
Correspondence re: G. C. de Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6: 1267-1272, 2000.通信：关于G. C. de Gast等人，皮下注射粒细胞巨噬细胞集落刺激因子、低剂量白细胞介素2和干扰素α联合免疫疗法治疗进展期转移性黑色素瘤和肾细胞癌的I期试验。《临床癌症研究》，6: 1267 - 1272，2000年。
Clin Cancer Res. 2000 Oct;6(10):4167.
2
Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.皮下注射粒细胞巨噬细胞集落刺激因子、低剂量白细胞介素2和干扰素α联合免疫疗法用于进展期转移性黑色素瘤和肾细胞癌的I期试验
Clin Cancer Res. 2000 Apr;6(4):1267-72.
3
Immunotherapy of renal cell carcinoma with granulocyte macrophage colony stimulating factor and very low dose interleukin-2.应用粒细胞巨噬细胞集落刺激因子和极低剂量白细胞介素-2对肾细胞癌进行免疫治疗。
Oncol Rep. 2005 Apr;13(4):751-6.
4
Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy.
Eur Urol. 2005 Sep;48(3):527-33. doi: 10.1016/j.eururo.2005.03.031. Epub 2005 Apr 11.
5
Granulocyte macrophage-colony stimulating factor plus interleukin-2 plus alpha-interferon plus 5-fluorouracil in the treatment of metastatic renal cell cancer: induction of CD80/86+ T cells indicates adverse outcome.粒细胞巨噬细胞集落刺激因子加白细胞介素-2加α干扰素加5-氟尿嘧啶治疗转移性肾细胞癌：CD80/86+T细胞的诱导提示不良预后。
J Immunother. 2009 Jul-Aug;32(6):667-75. doi: 10.1097/CJI.0b013e3181a950e5.
6
Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.α干扰素与低剂量白细胞介素-2联合免疫疗法治疗日本转移性肾细胞癌患者的临床疗效
Urol Oncol. 2009 Nov-Dec;27(6):598-603. doi: 10.1016/j.urolonc.2008.07.023. Epub 2008 Sep 25.
7
Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens.转移性肾细胞癌中干扰素-α与低剂量白细胞介素-2联合免疫治疗反应的预测：根治性肾切除术标本中潜在分子标志物的表达模式
Int J Urol. 2009 May;16(5):465-71. doi: 10.1111/j.1442-2042.2009.02262.x.
8
Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.2006年及以后细胞因子疗法在转移性肾细胞癌治疗中的作用
J Clin Oncol. 2006 Dec 10;24(35):5584-92. doi: 10.1200/JCO.2006.08.1638.
9
Adjuvant therapy for malignant melanoma.恶性黑色素瘤的辅助治疗
Expert Rev Anticancer Ther. 2004 Oct;4(5):823-35. doi: 10.1586/14737140.4.5.823.
10
Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma.在进展期转移性肾细胞癌患者中采用皮下注射GM-CSF、低剂量IL-2和IFN-α进行同步免疫治疗。
Br J Cancer. 2003 May 6;88(9):1346-51. doi: 10.1038/sj.bjc.6600915.